Search for Clinical Trial Results
Geographic Atrophy - 34 Studies Found
Status | Study |
Completed |
Study Name: A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy Condition: Geographic Atrophy Date: 2010-10-25 Interventions:
|
Recruiting |
Study Name: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima B) Condition: Geographic Atrophy Date: 2015-03-23 Interventions: Other: No intervention No intervention administered in this study |
Recruiting |
Study Name: Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) Condition: Geographic Atrophy Date: 2016-04-18 Interventions: Drug: Lampalizumab Lampalizumab 10 mg will be administered every 4 or 6 weeks according to the frequency |
Recruiting |
Study Name: An Epidemiologic Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (Proxima A). Condition: Geographic Atrophy Date: 2015-06-19 Interventions: Other: No intervention No intervention administered in this study |
Recruiting |
Study Name: Micropulse Laser for Geographic Atrophy Condition:
Date: 2013-02-25 Interventions: Procedure: Micropulse Between 1 and 3 sessions of micropulse laser will be applied in the inferior hemir |
Completed |
Study Name: Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration Condition:
Date: 2007-01-30 Interventions: Drug: Fenretinide Once daily 30 minutes after the evening meal for 24 months |
Terminated |
Study Name: Geographic Atrophy Treatment Evaluation Condition:
Date: 2009-04-27 Interventions:
|
Completed |
Study Name: Safety and Efficacy Assessment Treatment Trials of Emixustat Hydrochloride Condition: Geographic Atrophy Date: 2013-02-28 Interventions:
|
Completed |
Study Name: Geographic Atrophy and Intravitreal Ranibizumab Injections Condition:
Date: 2015-02-20 Interventions: Drug: Ranibizumab The medication Ranibizumab is routine standard of care for patients with wet AMD, and |
Recruiting |
Study Name: A Phase 2/3 Trial to Assess the Safety and Efficacy of Intravitreous Administration of Zimura® (Anti-C5 Aptamer) in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Condition:
Date: 2016-02-16 Interventions:
|